Organon & Co (OGN)
18.07
-0.71
(-3.78%)
USD |
NYSE |
Nov 01, 16:00
18.02
-0.05
(-0.28%)
After-Hours: 20:00
Organon 1 Year Total Returns (Daily): 31.91% for Nov. 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 01, 2024 | 31.91% |
October 31, 2024 | 35.80% |
October 30, 2024 | 28.44% |
October 29, 2024 | 27.61% |
October 28, 2024 | 24.82% |
October 25, 2024 | 17.27% |
October 24, 2024 | 16.86% |
October 23, 2024 | 18.90% |
October 22, 2024 | 16.70% |
October 21, 2024 | 17.37% |
October 18, 2024 | 15.61% |
October 17, 2024 | 14.75% |
October 16, 2024 | 13.80% |
October 15, 2024 | 11.39% |
October 14, 2024 | 11.76% |
October 11, 2024 | 11.79% |
October 10, 2024 | 11.22% |
October 09, 2024 | 13.70% |
October 08, 2024 | 16.75% |
October 07, 2024 | 16.88% |
October 04, 2024 | 19.86% |
October 03, 2024 | 19.88% |
October 02, 2024 | 19.06% |
October 01, 2024 | 16.00% |
September 30, 2024 | 17.85% |
Date | Value |
---|---|
September 27, 2024 | 23.64% |
September 26, 2024 | 18.85% |
September 25, 2024 | 13.83% |
September 24, 2024 | 15.15% |
September 23, 2024 | 15.50% |
September 20, 2024 | 10.17% |
September 19, 2024 | 13.53% |
September 18, 2024 | 9.75% |
September 17, 2024 | 12.48% |
September 16, 2024 | 14.28% |
September 13, 2024 | 13.61% |
September 12, 2024 | 11.62% |
September 11, 2024 | 9.61% |
September 10, 2024 | 11.38% |
September 09, 2024 | 11.88% |
September 06, 2024 | 10.51% |
September 05, 2024 | 8.78% |
September 04, 2024 | 7.33% |
September 03, 2024 | 6.66% |
August 30, 2024 | 7.09% |
August 29, 2024 | 6.76% |
August 28, 2024 | 8.89% |
August 27, 2024 | 9.64% |
August 26, 2024 | 12.67% |
August 23, 2024 | 9.09% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-56.37%
Minimum
Dec 08 2023
35.80%
Maximum
Oct 31 2024
-15.56%
Average
-19.25%
Median
Aug 31 2023
1 Year Total Returns (Daily) Benchmarks
Eli Lilly and Co | 48.68% |
Biomarin Pharmaceutical Inc | -20.72% |
Cassava Sciences Inc | 21.62% |
Ligand Pharmaceuticals Inc | 106.5% |
TG Therapeutics Inc | 165.8% |